- Home
- ALGS vs HHS Comparison
ALGS vs HHS Comparison
Compare ALGS & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALGS | HHS |
|---|---|---|
| Founded | 2018 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.6M | 34.0M |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ALGS | HHS |
|---|---|---|
| Price | $4.96 | $3.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $52.38 | N/A |
| AVG Volume (30 Days) | 36.2K | ★ 39.2K |
| Earning Date | 11-05-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 88.30 | ★ 97.35 |
| EPS | N/A | ★ N/A |
| Revenue | $2,186,000.00 | ★ $159,570,000.00 |
| Revenue This Year | $1,562.10 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.98 | $2.00 |
| 52 Week High | $13.69 | $4.67 |
Technical Indicators
Market Signals| Indicator | ALGS | HHS |
|---|---|---|
| Relative Strength Index (RSI) | 36.14 | 24.92 |
| Support Level | N/A | $3.40 |
| Resistance Level | $6.91 | $4.45 |
| Average True Range (ATR) | 0.36 | 0.16 |
| MACD | -0.04 | -0.10 |
| Stochastic Oscillator | 19.23 | 24.56 |
Price Performance
Historical ComparisonAbout ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The company operates three business segments: Revenue Solutions; Customer Care; and Fulfillment & Logistics Services. It derives maximum revenue from Fulfillment & Logistics Services segment. The Fulfillment & Logistics Services segment includes printing, lettershop, advanced mail optimization (including commingling services), logistics and transportation optimization, monitoring and tracking, to support traditional and specialized mailings. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.